GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cyclo 3 PSS Corp (OTCPK:CYPS) » Definitions » Loans Receivable

Switch to:

Cyclo 3 PSS (Cyclo 3 PSS) Loans Receivable : $0.00 Mil (As of . 20)

View and export this data going back to . Start your Free Trial

What is Cyclo 3 PSS Loans Receivable?

Cyclo 3 PSS's Loans Receivable for the quarter that ended in . 20 was $0.00 Mil.

Cyclo 3 PSS Loans Receivable Historical Data

The historical data trend for Cyclo 3 PSS's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclo 3 PSS Loans Receivable Chart

Cyclo 3 PSS Annual Data

Trend

Loans Receivable

Cyclo 3 PSS Quarterly Data

Loans Receivable

Cyclo 3 PSS Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Cyclo 3 PSS Loans Receivable Related Terms

Thank you for viewing the detailed overview of Cyclo 3 PSS's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclo 3 PSS (Cyclo 3 PSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cyclo 3 PSS Corp (OTCPK:CYPS) » Definitions » Loans Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7105 South Highland Drive, Suite No. 102, Salt Lake City, UT, USA, 84121

Website

Cyclo 3 PSS Corp is engaged in the research and development of technologies for the sterilization and/or disinfection of surgical and medical instruments, the manufacture, sale and installation of ozone washing and laundry sorting & counting systems.

Cyclo 3 PSS (Cyclo 3 PSS) Headlines

No Headlines

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.